Shares of Amneal Pharmaceuticals, Inc. (AMRX) rose 3% in pre-market trading on Tuesday after the company announced two major positive developments: an upward revision of its adjusted profit forecast for 2024 and a strategic agreement to acquire Kashiv Biosciences for $1.1 billions.

老虎证券2026/04/22 10:55

Show original

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.